Gabriele Missale

Gabriele Missale


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2008 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
Antonino MusolinoAntonino Musolino
Antonino Musolino
NNNadia Naldi
Nadia Naldi
BBBeatrice Bortesi
Beatrice Bortesi
DPDebora Pezzuolo
Debora Pezzuolo
MCMarzia Capelletti
Marzia Capelletti
AAAndrea Ardizzoni
Andrea Ardizzoni
Purpose: The anti–HER-2/neu monoclonal antibody trastuzumab has been shown to engage both activatory (fragment C receptor [FcγR]IIIa; FcγRIIa) and inhibitory (FcγRIIb) antibody receptors and FcγR polymorphisms have been identified that may affect the antibody-dependent cell-mediated cytotoxicity (ADCC) of natural-killer cells/monocytes. In this study, we tested whether FcγR polymorphisms are associated with clinical outcome of patients with breast cancer who received trastuzumab.Patients and Methods: Fifty-four consecutive patients with HER-2/neu–amplified breast cancer receiving trastuzumab plus taxane for metastatic disease were evaluated for genotype for the FcγRIIIa-158 valine(V)/phenylalanine(F), FcγRIIa-131 histidine(H)/arginine(R), and FcγRIIb-232 isoleucine(I)/threonine(T) polymorphisms. Trastuzumab-mediated ADCC of patients' peripheral blood mononuclear cells (PBMCs) was measured by chromium-51 release using a HER-2/neu–expressing human breast cancer cell line as a target. Controls comprised thirty-four patients treated with taxane alone.Results: Our population was in Hardy-Weinberg equilibrium except for the FcγRIIb polymorphism. The FcγRIIIa-158 V/V genotype was significantly correlated with objective response rate (ORR) and progression-free survival (PFS). Also, there was trend significance in ORR and PFS for the FcγRIIa-131 H/H genotype. The combination of the two favorable genotypes (VV and/or H/H) was independently associated with better ORR and PFS compared with the other combinations. The ADCC analysis showed that V/V and/or H/H PBMCs had a significantly higher trastuzumab-mediated cytotoxicity than PBMCs harboring different genotypes.Conclusion: These data support for the first time the hypothesis that FcγR-mediated ADCC plays an important role in the clinical effect of trastuzumab. Prospective studies are needed to confirm the role of FcγR polymorphisms in predicting clinical outcome of patients with breast cancer treated with trastuzumab-based therapy.

15 April 2007 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
Carolina BoniCarolina Boni
Carolina Boni
Paola FisicaroPaola Fisicaro
Paola Fisicaro
CVCaterina Valdatta
Caterina Valdatta
BABarbara Amadei
Barbara Amadei
PVPaola Di Vincenzo
Paola Di Vincenzo
CFCarlo Ferrari
Carlo Ferrari
Dysfunctional CD8+T cells present in chronic virus infections can express programmed death 1 (PD-1) molecules, and the inhibition of the engagement of PD-1 with its ligand (PD-L1) has been reported to enhance the antiviral function of these T cells. We took advantage of the wide fluctuations in levels of viremia which are typical of chronic hepatitis B virus (HBV) infection to comprehensively analyze the impact of prolonged exposure to different virus quantities on virus-specific T-cell dysfunction and on its reversibility through the blocking of the PD-1/PD-L1 pathway. We confirm that chronic HBV infection has a profound effect on the HBV-specific T-cell repertoire. Despite the use of a comprehensive panel of peptides covering all HBV proteins, HBV-specific T cells were rarely observed directly ex vivo in samples from patients with chronic infection, in contrast to those from patients with acute HBV infection. In chronic HBV infection, virus-specific T cells were detected mainly in patients with lower levels of viremia. These HBV-specific CD8+T cells expressed PD-1, and their function was improved by the blocking of PD-1/PD-L1 engagement. Thus, a broad spectrum of anti-HBV immunity is expressed by patients with chronic HBV infection and this spectrum is proportional to HBV replication levels and can be improved by blocking the PD-1/PD-L1 pathway. This information may be useful for the design of immunotherapeutic strategies to complement and optimize available antiviral therapies.

1 August 1996 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GMGabriele Missale
Gabriele Missale
RBR Bertoni
R Bertoni
VLV Lamonaca
V Lamonaca
AVA Valli
A Valli
MMM Massari
M Massari
CFC Ferrari
C Ferrari
The anti-viral T cell response is believed to play a central role in the pathogenesis of hepatitis C virus infection. Since chronic evolution occurs in > 50% of HCV infections, the sequential analysis of the T cell response from the early clinical stages of disease may contribute to define the features of the T cell response associated with recovery or chronic viral persistence. For this purpose, 21 subjects with acute hepatitis C virus infection were sequentially followed for an average time of 44 wk. Twelve patients normalized transaminase values that remained normal throughout the follow-up period; all but two cleared hepatitis C virus-RNA from serum. The remaining nine patients showed persistent viremia and elevated transaminases. Analysis of the peripheral blood T cell proliferative response to core, E1, E2, NS3, NS4, and NS5 recombinant antigens and synthetic peptides showed that responses to all hepatitis C virus antigens, except E1, were significantly more vigorous and more frequently detectable in patients who normalized transaminase levels than in those who did not. By sequential evaluation of the T cell response, a difference between the two groups of patients was already detectable at the very early stages of acute infection and then maintained throughout the follow-up period. The results suggest that the vigor of the T cell response during the early stages of infection may be a critical determinant of disease resolution and control of infection.

1 November 2006 in Journal of Virology
Verified
Journal Article
Closed access
SUSimona Urbani
Simona Urbani
BABarbara Amadei
Barbara Amadei
DTDaniela Tola
Daniela Tola
MMMarco Massari
Marco Massari
SSSimona Schivazappa
Simona Schivazappa
CFCarlo Ferrari
Carlo Ferrari
Hepatitis C virus (HCV)-specific CD8 cell exhaustion may represent a mechanism of HCV persistence. The inhibitory receptor PD-1 has been reported to be up-regulated in exhausted CD8 cells. Therefore, we studied PD-1 expression longitudinally during acute HCV infection. Most HCV-specific CD8 cells expressed PD-1 at the time of acute illness, irrespective of the final outcome. PD-1 expression declined with the acquisition of a memory phenotype and recovery of an efficient CD8 cell function in resolving HCV infections, whereas high levels were maintained when HCV persisted and HCV-specific CD8 cells remained dysfunctional. Blocking PD-1/PDL-1 interaction with an anti-PDL-1 antibody improved the capacity of expansion of virus-specific CD8 cells.

1 February 2010 in Gastroenterology
Verified
Journal Article
Open access
PDF file
Paola FisicaroPaola Fisicaro
Paola Fisicaro
CVCaterina Valdatta
Caterina Valdatta
MMMarco Massari
Marco Massari
ELElisabetta Loggi
Elisabetta Loggi
EBElisabetta Biasini
Elisabetta Biasini
CFCarlo Ferrari
Carlo Ferrari
Hepatitis B virus (HBV) causes self-limited infections in the majority of adult patients; however, in less than 5% of infected adults and in a larger proportion of children, HBV infection evolves into a chronic liver disease, which may lead to severe sequelae. Available data indicate a vigorous and broad T-cell response in patients with acute self-limited hepatitis B, which is in contrast with the much weaker and often barely detectable T-cell response observed during chronic HBV infections, in which HBV-specific T-lymphocytes have been described to be deeply dysfunctional.1 x 1 Bertoletti, A. and Ferrari, C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003; 38: 4–13 Google Scholar See all References , 2 x 2 Rehermann, B. and Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5: 215–229 Google Scholar See all References , 3 x 3 Das, A., Hoare, M., Davies, N. et al. Functional skewing of the global CD8 T-cell population in chronic hepatitis B virus infection. J Exp Med. 2008; 205: 2111–2124 Google Scholar See all References Among the different mechanisms proposed to explain such a functional T-cell impairment, exhaustion by persistent exposure to high antigen concentrations represents a possible cause,4 x 4 Chang, J.J., Thompson, A.J.V., Visvanathan, K. et al. The phenotype of hepatitis B virus-specific T cells differs in the liver and blood in chronic hepatitis B virus infection. Hepatology. 2007; 46: 1332–1340 Google Scholar See all References , 5 x 5 Zhang, Z., Zhang, J.-Y., Wherry, E.J. et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008; 134: 1938–1949 Abstract | Full Text | Full Text PDF | Scopus (94) | Google Scholar See all References , 6 x 6 Boni, C., Fisicaro, P., Valdatta, C. et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007; 81: 4215–4225 Google Scholar See all References and T-cell attrition through Bcl2 signalling7 x 7 Lopes, A.R., Kellam, P., Das, A. et al. Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection. J Clin Invest. 2008; 118: 1835–1845 Google Scholar See all References as well as impaired T-cell receptor signaling through the ζ-chain3 x 3 Das, A., Hoare, M., Davies, N. et al. Functional skewing of the global CD8 T-cell population in chronic hepatitis B virus infection. J Exp Med. 2008; 205: 2111–2124 Google Scholar See all References have been shown to be involved.

1 January 2004 in Gastroenterology
Verified
Journal Article
Open access
PDF file
TPTeresa Pollicino
Teresa Pollicino
GSGiovanni Squadrito
Giovanni Squadrito
GCGiovanni Cerenzia
Giovanni Cerenzia
Irene CacciolaIrene Cacciola
Irene Cacciola
GRGiuseppina Raffa
Giuseppina Raffa
GRGiovanni Raimondo
Giovanni Raimondo
Math Eq: Occult hepatitis B virus (HBV) infection is characterized by persistence of HBV DNA into the tissue of hepatitis B surface antigen-negative individuals. The clinical relevance of this peculiar infection is still under debate. In particular, the impact of occult HBV infection in cases of hepatocellular carcinoma (HCC) is uncertain. We investigated the prevalence and molecular status of occult HBV in patients with HCC. Math Eq: We tested tumor tissues from 107 patients with HCC and the corresponding nontumor liver tissue from 72 of these patients for HBV DNA. We also examined liver specimens from 192 patients with chronic hepatitis. All cases were hepatitis B surface antigen negative. Covalently closed circular HBV genomes, HBV transcripts, and viral integrated forms were investigated in cases of HCC found positive for occult HBV. Math Eq: Viral DNA was detected in 68 of 107 cases of HCC (63.5%) and in 63 of 192 cases of chronic hepatitis (32.8%) (P < 0.0001; odds ratio, 3.6; 95% confidence interval, 2.2–5.9). The significant association of occult HBV with HCC was irrespective of age, sex, and contemporary hepatitis C virus infection. Both integrated viral DNA and covalently closed circular HBV genomes were detected in patients with occult HBV. Moreover, the presence of free HBV genomes was associated with persistence of viral transcription and replication. Math Eq: Our findings provide clear evidence that occult HBV is a risk factor for development of HCC and show that the potential mechanisms whereby overt HBV might induce tumor formation are mostly maintained in cases of occult infection.